Epidemiology and surveillance of hepatocellular carcinoma.
about
Alcohol and Viral Hepatitis: Role of Lipid RaftsStrategies to increase the resectability of hepatocellular carcinomaReal-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON DataStratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.A carbohydrate-grafted nanovesicle with activatable optical and acoustic contrasts for dual modality high performance tumor imagingFamilial correlations of onset age of hepatocellular carcinoma: a population-based case-control family study.Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivoSignificance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.Hepatocellular carcinoma in Asia: Prevention strategy and planning.Cartilage oligomeric matrix protein: A novel non-invasive marker for assessing cirrhosis and risk of hepatocellular carcinoma.Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver diseaseTargeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma.Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United StatesHypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study.Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinomaThe Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan.Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran.Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials.Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue TherapyHepatocellular carcinoma with obstructive jaundice: endoscopic and percutaneous biliary drainage.Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging.Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.The NQO1 C609T polymorphism and hepatocellular carcinoma risk.A clinical perspective on the role of chronic inflammation in gastrointestinal cancer.Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.Wide variation in estimates of global prevalence and burden of chronic hepatitis B and C infection cited in published literature.Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database.Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.Cold-inducible RNA-binding protein promotes the development of liver cancerAssessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study.Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.Lack of Any Relationship Between Circulating Autoantibodies and Interleukin–6 Levels in Egyptian Patients Infected with the Hepatitis C VirusCombined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma.
P2860
Q26773213-D0D44EA0-127B-4BD5-9ACB-CF09F4E068A1Q26795530-157182C0-70F8-4548-9FEB-DC40087EF2D6Q31048824-B521645E-631B-4A9A-8B59-2ADA9BE42FCFQ33621633-C02B12D3-91F5-496C-9541-596E64FA9424Q33869355-7097FE3C-D0A4-4552-802E-B78D367DAF7BQ34233259-F3E0D5B8-95A9-4CD5-B905-88A64067E4C3Q34402163-C9619E6F-387B-41AD-A929-7634E52FDE1FQ34696921-4C29F9C7-64F7-43AA-86E3-B400FC590085Q35790424-7DA32D3C-986A-4372-A3B5-B418EA46E4D5Q35864817-07EAB2EE-ABFD-4A3E-B7A1-E3C7753BB9A5Q36046058-29062591-DF9A-45AF-B6DA-7179DFDAB8EFQ36102532-A2D59AFE-0E91-483C-B711-36431720982AQ36181189-A107A8D4-8532-4F78-B61F-B3DEE0C77BB4Q36356419-E406BAE3-FA59-449C-8483-2F63ECC1434BQ36423170-0CFB5401-8F76-486B-BD09-B0FF6DF2511CQ36540044-21E0A1F6-C2AB-45B3-B1B7-E07493616915Q36580984-650541AC-51CF-4E0A-9D00-69532A1ADE27Q36905681-EEE3521C-1EB1-422F-B3F7-D3139AA2F48EQ37031706-5CB9F487-8983-480D-8162-005BC8608A21Q37328442-7ADDC96A-9FA0-458F-A69C-868B1297769BQ37350820-922E270F-24DE-417C-8846-1B812DF1070DQ37637658-CF3AB0E1-A9F9-4988-B47F-58B12F39A8F9Q37716237-EC997117-ADC1-4015-B664-9E9F9A2D23ECQ38069065-DC57CA06-3ADE-4145-83AB-FB05209B0732Q38083432-C7D3ED61-7D33-49AF-BE96-46B9BEE08D0AQ38083435-1353B3E8-A978-4974-B192-669C00C30A7AQ38188524-6C66256B-9551-4069-9D8E-E85742B3B30EQ38241837-E8BF48C3-698D-4BCB-8D3D-C8EE7D3E84DCQ38366584-AA027478-D9E6-4893-8ECB-5A6F12CE297CQ38793776-900E6F40-FA60-4B8E-B37E-64B9CE52D9DBQ38939495-B16EB622-FF92-405B-A589-CCD4220AA672Q38948642-2F0C9366-D3D2-4A8E-A7B2-0F27AF38F829Q38974538-6D63106F-839A-49E1-9986-536142B38F0FQ39959260-223E0C74-7376-41C2-8C4E-B2531E24D558Q40159677-DD5E2A2F-5FB9-451E-8DFD-570B9D8514DBQ40330653-0C034CF8-6E7D-4C72-94D4-E7C826DBE30DQ40391710-D1249F49-A362-4815-BE37-4FA2264BFE70Q40572955-AE90D9A0-7EE3-4573-8EBA-33AF0F161745Q41646089-A1CEEE16-9211-4ED4-9394-103E1F7D7775Q42376378-29B1DE33-D51E-432F-9CFE-CF786536857F
P2860
Epidemiology and surveillance of hepatocellular carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology and surveillance of hepatocellular carcinoma.
@en
Epidemiology and surveillance of hepatocellular carcinoma.
@nl
type
label
Epidemiology and surveillance of hepatocellular carcinoma.
@en
Epidemiology and surveillance of hepatocellular carcinoma.
@nl
prefLabel
Epidemiology and surveillance of hepatocellular carcinoma.
@en
Epidemiology and surveillance of hepatocellular carcinoma.
@nl
P2860
P356
P1433
P1476
Epidemiology and surveillance of hepatocellular carcinoma.
@en
P2093
Do Young Kim
Kwang-Hyub Han
P2860
P356
10.1159/000339016
P577
2012-06-01T00:00:00Z